EFFECT OF THE SGLT2 INHIBITOR DAPAGLIFLOZIN ON RENAL FUNCTION AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN ELDERLY PATIENTS WITH EARLY DIABETIC KIDNEY DISEASE

EFFECT OF THE SGLT2 INHIBITOR DAPAGLIFLOZIN ON RENAL FUNCTION AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN ELDERLY PATIENTS WITH EARLY DIABETIC KIDNEY DISEASE

Objective To investigate the effect of the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin on renal function and renin-angiotensin-aldosterone system (RAAS) in elderly patients with early diabetic kidney disease (DKD). Methods A total of 97 elderly patients with type 2 diabetes mellit...

Full description

Bibliographic Details
Main Author:	SUN Qian, LIU Guibo, FENG Wenjing, SONG Jie, DAI Liming, KONG Yue, XU Yinfei, CAO Caixia
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Precision Medicine 2023-02-01
Series:	精准医学杂志
Subjects:	sodium-glucose transporter 2 inhibitors\|diabetic nephropathies\|renin-angiotensin system\|albuminuria\|glomerular filtration rate
Online Access:	https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/202301018.pdf

Similar Items

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Renin-angiotensin system antagonists, glomerular filtration rate and blood pressure
by: D.D. Ivanov
Published: (2018-02-01)

Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
by: Karl Andersen
Published: (2009-03-01)

Efficacy of valsartan in the therapy of persistent microalbuminuria in normotensive patients with type 1 diabetes mellitus
by: Dragović Tamara, et al.
Published: (2003-01-01)

Renin angiotensin aldosterone system in anaphylactic reactions induced by immunotherapy
by: Mehmet Karaayvaz, et al.
Published: (1998-01-01)

Medicinal chemistry of the renin-angiotensin system /
by: Timmermans, P. B. M. W. M., et al.
Published: (1994)

The Effect of Moderate Hypothermia on Renin-Angiotensin – Aldosterone System in Male Rats
by: Masoumeh Kourosh Arami, et al.
Published: (2004-06-01)

Beyond the circulating renin angiotensin aldosterone system
by: Walmor eDe Mello
Published: (2014-07-01)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
by: Yan-Huan Feng, et al.
Published: (2016-01-01)

Regulation of Monocytes/Macrophages by the Renin–Angiotensin System in Diabetic Nephropathy: State of the Art and Results of a Pilot Study
by: Claudine Moratal, et al.
Published: (2021-06-01)

Correlation with renin-angiotensin-aldosterone and glomerular filtration rate in chronic renal failure patients
by: Fatimah Kadhim Ibrahim AL-Mahdawi ,, et al.
Published: (2023-06-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Renin–Angiotensin–Aldosterone System and Immunomodulation: A State-of-the-Art Review
by: Driss Laghlam, et al.
Published: (2021-07-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
by: Bongeka Cassandra Mkhize, et al.
Published: (2022-05-01)

Effects of sodium-glucose co-transporter 2 (SGLT2) inhibition on renal function and albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis
by: Lubin Xu, et al.
Published: (2017-06-01)

Regulation of Male Fertility by the Renin-Angiotensin System
by: Marta Gianzo, et al.
Published: (2020-10-01)

SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients
by: Vladimir V Salukhov, et al.
Published: (2021-01-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Renin-angiotensin-aldosterone system inhibition decreased contrast-associated acute kidney injury in chronic kidney disease patients
by: Yi-Ting Chen, et al.
Published: (2021-01-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
by: R de O. Caminhotto, et al.
Published: (2016-07-01)

The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

Study of Anthocyanin Molecule Blocking as Anti-Hypertensive through the Pathway of the Renin-Angiotensin-Aldosterone System (RAAS)
by: Dwi Budiarto, et al.
Published: (2023-05-01)

Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
by: Monika Cahova, et al.
Published: (2021-03-01)

Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01)

Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study
by: Sehoon Park, et al.
Published: (2019-09-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-05-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-05-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-05-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-06-01)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

Posterior urethral valves: Persistent renin angiotensin system activation after valve ablation and role of pre-emptive therapy with angiotensin converting enzyme-inhibitors on renal recovery
by: Minu Bajpai, et al.
Published: (2013-01-01)

Modern Markers of Renal Damage in Diabetes Mellitus
by: Lyubov I. Kolesnikova
Published: (2020-03-01)

Glycosylated hemoglobin as a forecast factor of progressing of diabetic nephropathy in patients with diabetes type 1.
by: N. O. Pertseva, et al.
Published: (2017-12-01)